IP Library › Patent Application 16167250
Patent Application
App. No. 16/167,250

COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/167,250
Abstract

The disclosure provides Group 6 complexes, which, in some embodiments, are useful for catalyzing olefin metathesis reactions. In some embodiments, the compounds are compounds of the following formula: wherein: M is a Group 6 metal atom; X is an oxygen atom, ═N—R 5 , ═N—N(R 5 )(R 5′ ) or ═N—O—R 5 , R 5 and R 5′ independently being various substituents, such as aryl or heteroaryl, each optionally substituted; n is 0 or 1; R z is a neutral ligand; R 1 is hydrogen or an organic substituent; R 2 is an aryl or heteroaryl group, each optionally substituted; R 3 is an anionic ligand; and R 4 is an anionic ligand, such as a pyrrolide, a pyrazolide, an imidazolide, an indolide, an azaindolide, or an indazolide, each optionally substituted.

Claims (42)

1 . A compound of Formula (II)

wherein:

M is a molybdenum atom or a tungsten atom;

R 101 is phenyl, alkyl, or cycloalkyl, each of which is optionally substituted;

R 102 pyrrolyl or indolyl, each of which is optionally substituted;

R 103 is phenyl, optionally substituted;

R 104 is a hydrogen atom;

R105 is —O—(C 1-6 alkyl) or —CH 2 —O—(C 1-6 alkyl); and

R 106 and R 107 are independently a hydrogen atom, C 1-6 alkyl, C 1-6 alkoxy, or a halogen atom.

2 . The compound of claim 1 , wherein R 101 is phenyl, 2,6-dichlorophenyl, 2,6-dimethylphenyl, 2,6-diisopropylphenyl, 2-trifluoromethylphenyl, pentafluorophenyl, tert-butyl, or 1-adamantyl.

3 . The compound of claim 1 , wherein R 102 is pyrrol-1-yl, 2,5-dimethylpyrrol-1-yl, 2,5-diphenylpyrrol-1-yl, or indol-1-yl.

4 . The compound of claim 1 , wherein R 103 is 2,6-diphenylphenyl or 4-bromo-2,3,5,6-tetraphenylphenyl, or

wherein R 103 is:

wherein “iPr” refers to isopropyl, and “OTBDMS” refers to tert-butyldimethylsilyloxy.

5 . The compound of claim 1 , wherein R 105 is methyloxy, ethyloxy, or isopropyloxy.

6 . The compound of claim 1 , wherein R 106 and R 107 are independently a hydrogen atom, methyl, a halogen atom, or methyloxy.

7 . A method for carrying out a metathesis reaction, the method comprising:

providing a first compound having one or more carbon-carbon double bonds; and

reacting the first compound via a metathesis reaction in the presence of a compound of claim 1 .

8 . The method of claim 7 , wherein the first compound has two or more carbon-carbon double bonds.

9 . The method of claim 8 , wherein the metathesis reaction is a ring-closing metathesis reaction between two of the two or more carbon-carbon double bonds of the first compound.

10 . A method of carrying out a metathesis reaction, the method comprising:

providing a first compound having one or more carbon-carbon double bond and a second compound having one or more carbon-carbon double bonds; and

reacting the first compound and the second compound via a metathesis reaction in the presence of a compound of claim 1 .

11 . The method of claim 10 , wherein the first compound and the second compound are the same compound.

12 . The method of claim 10 , wherein the first compound and the second compound are not the same.

13 . The method of claim 12 , wherein the first compound is an internal olefin.

14 . The method of claim 13 , wherein the second compound is a short-chain alkene.

15 . The method of claim 14 , wherein the short-chain alkene is ethylene.

16 . The method of claim 11 wherein the first compound is an unsaturated ester.

17 . The method of claim 15 , wherein the first compound is an unsaturated ester.

18 . The compound of claim 1 , wherein M is a tungsten atom.

19 . The compound of claim 1 , wherein:

M is a tungsten atom;

R 101 is 2,6-dichlorophenyl;

R 102 is 2,5-dimethylpyrrol-1-yl;

R 103 is:

R 104 is hydrogen;

R 105 is methyloxy;

R 106 is hydrogen; and

R 107 is hydrogen.

20 . The compound of claim 1 , comprising a neutral ligand.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE US APPLICATION NO. 13/639,067 AND US APPLICATION NO. 14/001,811 WERE RECORDED IN ERROR PREVIOUSLY RECORDED ON REEL 050392 FRAME 719. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 4, 2020
From: XIMO AG
To: VERBIO VEREINIGTE BIOENERGIE AG
Reel/Frame 053705/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2019
From: XIMO AG
To: VERBIO VEREINIGTE BIOENERGIE AG
Reel/Frame 050392/0719 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 047292 FRAME 0493. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 13, 2018
From: TOTH, FLORIAN; FRATER, GEORG; ONDI, LEVENTE
To: XIMO AG
Reel/Frame 047822/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2018
From: TOTH, FLORIAN; FRATER, GEORG; ONDI, LEVENTE
To: XIMO AB
Reel/Frame 047292/0493 →